Literature DB >> 12428788

Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest.

Chih-Yi Hsu1, Donald Ming-Tak Ho, Ching-Fen Yang, Chiung-Ru Lai, I-Ting Yu, Hung Chiang.   

Abstract

Although there are criteria for interpretation of the staining results for Her-2/neu in the DAKO HercepTest, the determination of staining intensity and percentage of complete membrane staining is subjective. We studied 46 cases of invasive breast carcinoma to evaluate interobserver reproducibility among 5 pathologists. Complete agreement was achieved in 22 (48%) of46 cases. Generalized kappa values indicated substantial agreement (0.80). Discrepancies between negative (0, 1+) and positive (2+, 3+) results occurred in 2 cases (kappa = 0.96). One was because of a tangential cut of the basal part of the tumor that mimicked complete membranous staining, and the other was a borderline case that revealedfocal (5%-15%) complete membranous staining. Distinguishing weakly (2+) from strongly (3+) positive results showed agreement in only 13 (59%) of 22 positive cases (kappa = 0.38). If more than 50% of tumor cells revealing strong complete membrane staining were regarded as strongly positive, agreement would be improved (kappa = 0.78). While there was a high percentage (70%-80%) of negative cases during routine evaluation, the good interobserver agreement and high negative predictive value made immunohistochemical analysis an effective screening test to exclude negative cases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428788     DOI: 10.1309/6ANB-QXCF-EHKC-7UC7

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

1.  Quantitation of HER2/neu expression in primary gastroesophageal adenocarcinomas using conventional light microscopy and quantitative image analysis.

Authors:  Jennifer Jeung; Roshan Patel; Lizette Vila; Dara Wakefield; Chen Liu
Journal:  Arch Pathol Lab Med       Date:  2012-06       Impact factor: 5.534

2.  Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy.

Authors:  Marios A Gavrielides; Brandon D Gallas; Petra Lenz; Aldo Badano; Stephen M Hewitt
Journal:  Arch Pathol Lab Med       Date:  2011-02       Impact factor: 5.534

3.  High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma.

Authors:  Yan Cui; Ming Niu; Xianyu Zhang; Zhenbin Zhong; Ji Wang; Da Pang
Journal:  Tumour Biol       Date:  2015-07-14

4.  Evaluation of the HER2 and Hormone Receptor Status in Metastatic Breast Cancer Using Cell Blocks: A Multi-Institutional Study.

Authors:  Rieko Nishimura; Yuya Murata; Kiyoshi Mori; Katsushige Yamashiro; Kazuya Kuraoka; Shu Ichihara; Kenichi Taguchi; Hiroyoshi Suzuki; Masahiro Ito; Natsumi Yamashita
Journal:  Acta Cytol       Date:  2018-05-15       Impact factor: 2.319

5.  Serum HER-2 concentration in patients with primary breast cancer.

Authors:  S-Y Kong; J H Kang; Y Kwon; H-S Kang; K-W Chung; S H Kang; D H Lee; J Ro; E S Lee
Journal:  J Clin Pathol       Date:  2006-02-03       Impact factor: 3.411

6.  Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer.

Authors:  Hela Masmoudi; Stephen M Hewitt; Nicholas Petrick; Kyle J Myers; Marios A Gavrielides
Journal:  IEEE Trans Med Imaging       Date:  2009-01-19       Impact factor: 10.048

7.  Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.

Authors:  S Sun; X Liang; X Zhang; T Liu; Q Shi; Y Song; Y Jiang; H Wu; Y Jiang; X Lu; D Pang
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

8.  Expression of ribosome-binding protein 1 correlates with shorter survival in Her-2 positive breast cancer.

Authors:  Xiaoshuan Liang; Shanshan Sun; Xianyu Zhang; Hao Wu; Weiyang Tao; Tong Liu; Wei Wei; Jingshu Geng; Da Pang
Journal:  Cancer Sci       Date:  2015-04-27       Impact factor: 6.716

9.  Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.

Authors:  Gulisa Turashvili; Samuel Leung; Dmitry Turbin; Kelli Montgomery; Blake Gilks; Rob West; Melinda Carrier; David Huntsman; Samuel Aparicio
Journal:  BMC Cancer       Date:  2009-05-29       Impact factor: 4.430

10.  Evaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell Carcinoma.

Authors:  Soheil Pardis; Yasaman Sardari; Mohammad Javad Ashraf; Azadeh Andisheh Tadbir; Hooman Ebrahimi; Sara Purshahidi; Bijan Khademi; Mohammad Javad Fattahi; Marzieh Hamzavi
Journal:  Iran J Otorhinolaryngol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.